Trending News
-
Market Movers
Microsoft Is Betting Big on NVIDIA GPUs — But Will Custom Chips Save Its AI Ambitions?
Microsoft has secured nearly half a million Nvidia GPUs in 2024 alone, surpassing rivals Google,…
Read More » -
-
-
-
-
-
-
-
Tech
-
Market Movers
Microsoft Is Betting Big on NVIDIA GPUs — But Will Custom Chips Save Its AI Ambitions?
Microsoft has secured nearly half a million Nvidia GPUs in 2024 alone, surpassing rivals Google, Amazon, and Meta given its…
Read More » -
Market Movers
SMCI Investigation Sparks Rally—Should Investors Be Concerned About Lingering Issues?
SMCI’s shares surged after an independent investigation found no evidence of fraud and the special committee's recommendation to strengthen governance…
Read More » -
Business
Is MicroStrategy’s Bitcoin Frenzy Setting It Up For A Crash?
MicroStrategy has been making headlines once again, fueled by its audacious Bitcoin-centric strategy and a meteoric stock price rise of…
Read More »
Biotech
-
Biotech
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
On December 3, 2024, the company announced groundbreaking results for its lead drug candidate, JANX007, a tumor-activated T-cell engager targeting…
Read More » -
Biotech
Why Maravai LifeSciences Could Be a Perfect Acquisition Target for Repligen
Maravai LifeSciences has recently caught the attention of Repligen as a potential acquisition target, marking it as a significant player…
Read More » -
Biotech
SmallCaps Daily Sits Down with Milton Werner, President and CEO of Inhibikase Therapeutics
CEO and President, Milton Werner shares Inhibikase's vision, achievements, and future endeavors in neurological diseases while highlighting the significant progress…
Read More »
Healthcare
-
Featured
SBC Medical Group: Dominating Japan’s Booming Aesthetic Market with Strong Financial Growth and Global Expansion Plans
Amidst this thriving landscape, SBC Medical Group Holdings (Nasdaq: SBC) has emerged as a leading provider in Japan, offering a…
Read More » -
Featured
TPOXX Failure is Massive-Opportunity for Nanoviricides’ NV-387 to Battle Clade 1/1b
Enter NanoViricides, Inc. (NYSE American: NNVC), a company at the forefront of developing groundbreaking solutions to combat viral infections. With…
Read More » -
Breaking
Healthcare Stocks: Thriving Amidst Economic Uncertainty
Despite economic concerns, the sell-off in big tech, rising interest rates and a looming recession, healthcare stocks are still going…
Read More »
-
Cannabis
Grove Inc (GRVI): Untouchable Leader Within the CBD-Based Industry?
Cannabidiol, commonly known as CBD, is a naturally occurring chemical compound found in cannabis plants…
Read More » -
-
-
